News Focus
News Focus
icon url

north40000

11/16/24 6:25 PM

#430565 RE: Jasbg #430564

Did you put any money in NVO shares? Was NVO doing any research concerning Ozempic in 2016 that produced any data re CVD, with or without Amarin? 

I assume you will likely be asleep when that CNN-TV program with Dr. Gupta discussing NVO's Ozempic airs in Denmark.
icon url

Number sleven

11/16/24 6:46 PM

#430566 RE: Jasbg #430564

Jasbg, I am an investor. Nothing that I do will effect the outcome for this company. Alex Denner has done nothing that the prior management team wasn't already doing. I am adding to my position because I believe the current strategy will succeed. When I tell you or others to sell I'm not being sarcastic. As an investor you have three choices. Buy, hold, or sell. Whining on a message board isn't productive. I think the company has enough cash to reach positive EU/ROW revenue. This investment hasn't "ended". That's childish. As an investor you need to continually evaluate the situation that the company is in. For Amarin, that's not a simple analysis. Do your research and ignore the share price.
Sleven,